Document is current
Any future updates will be listed below
-
Authors
Schmidt, Insa M. http://orcid.org/0000-0002-0420-6570
Surapaneni, Aditya L.
Zhao, Runqi http://orcid.org/0009-0004-3458-0194
Upadhyay, Dhairya http://orcid.org/0009-0009-3044-4335
Yeo, Wan-Jin
Schlosser, Pascal http://orcid.org/0000-0002-8460-0462
Huynh, Courtney
Srivastava, Anand
Palsson, Ragnar
Kim, Taesoo http://orcid.org/0000-0002-2589-7390
Stillman, Isaac E.
Barwinska, Daria http://orcid.org/0000-0002-0776-3030
Barasch, Jonathan
Eadon, Michael T. http://orcid.org/0000-0003-3066-2876
El-Achkar, Tarek M. http://orcid.org/0000-0003-4645-3614
Henderson, Joel
Moledina, Dennis G. http://orcid.org/0000-0002-9537-9038
Rosas, Sylvia E.
Claudel, Sophie E.
Verma, Ashish
Wen, Yumeng
Lindenmayer, Maja http://orcid.org/0000-0003-4162-9107
Huber, Tobias B. http://orcid.org/0000-0001-7175-5062
Parikh, Samir V.
Shapiro, John P.
Rovin, Brad H.
Stanaway, Ian B. http://orcid.org/0000-0002-0783-0918
Sathe, Neha A.
Bhatraju, Pavan K.
Coresh, Josef http://orcid.org/0000-0002-4598-0669
,
Rhee, Eugene P. http://orcid.org/0000-0002-4804-7583
Grams, Morgan E. http://orcid.org/0000-0002-4430-6023
Waikar, Sushrut S. http://orcid.org/0000-0003-4004-326X
- License Information
-
More Information
Article History
Received: 13 February 2024
Accepted: 5 August 2024
First Online: 27 August 2024
Competing interests
: S.S.W. reports personal fees from Public Health Advocacy Institute, CVS, Roth Capital Partners, Kantum Pharma, Mallinckrodt, Wolters Kluewer, GE Health Care, GSK, Allena Pharmaceuticals, Mass Medical International, Barron and Budd (vs Fresenius), JNJ, Venbio, Strataca, Takeda, Cerus, Pfizer, Bunch and James, Harvard Clinical Research Institute (aka Baim), Oxidien, Sironax, Metro Biotechnology, Biomarin, and Bain. S.E.R reports grant support to Joslin from Bayer and AstraZeneca. In addition, she has participated as advisory member for Bayer and AstraZeneca. D.G.M. is named co-inventor on a pending patent, “Methods and Systems for Diagnosis of Acute Interstitial Nephritis” and is a co-founder of the diagnostics company Predict AIN, LLC. Y.W. reports being an employee of Genentech and having stock and stock options in Roche at the time of final manuscript revision. The remaining authors declare that they have no competing interests.
